Pre-Market Stock Notes (DEC 27, 2006)
(AAPL) Apple’s options probe apparently has potential faked documentation.(BA) Boeing won a $1.5 Billion contract for Apache helicopters.(BIOV) BioVeris announces license agreement with Baxter on meningitis.(BMY) Bristol-Myers Squibb announces licensing agreement with Otsuka Pharma in Japan on Type II Diabetes.(BSG)…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
(AAPL) Apple’s options probe apparently has potential faked documentation.
(BA) Boeing won a $1.5 Billion contract for Apache helicopters.
(BIOV) BioVeris announces license agreement with Baxter on meningitis.
(BMY) Bristol-Myers Squibb announces licensing agreement with Otsuka Pharma in Japan on Type II Diabetes.
(BSG) BYSIS is reportedly considrring going private afterrecent troubles.
(CANM) Caneum was in a bid win team for part of a $5B government purchase contract.
(CDMS) Cadmus gets $24.75 buyout from Cenveo.
(CRXL) Crucell in cross-license pact with Merck.
(GVA) Granite Construction is part of a $420M highway contract win.
(HSP) Hospira launches generic version of Glaxosmithkline-GSK’s Zofran for cancer chemo nausea.
(KNTA) Kintera filed to sell 4M shares for holders.
(MNI) McClatchy agreed to sell the Star Tribune paper in Minneapolis for $530M.
(MNST) Monster Worldwide said it has completed all filings now to become current; will record $5M in one-time expenses.
(MRX) Medicis wins injectable wrinkle treatment approval from FDA.
(NBR) Nabors is reviewing stock options.
(OMRI) Omrix Biopharma files IND application with the FDA; received milestones.
(ULBI) Ultralife Batteries won $2.9M military battery contract.
(UNH) United Health options probe from SEC is now formal.
Jon C. Ogg
December 27, 2006
Contact [email protected] for any questions or corrections.

